Hippocampal neurogenesis is the lifelong production of new neurons in the central nervous system (CNS), and affects many physiological and pathophysiological conditions, including neurobehavioral disorders. The early postnatal stage is the most prominent neurogenesis period; however, the functional role of neurogenesis in this developing stage has not been well characterized. To understand the role of hippocampal neurogenesis in the postnatal developing period, we analyzed secretin, a neuropeptide, which is expressed significantly higher in the development stage. Secretin is a pleiotropic neuropeptide hormone that belongs to the secretin/VIP/glucagon peptide family. Although secretin was originally isolated in the gastrointestinal system, it has been found that secretin itself acts as a neuropeptide in the CNS. Here, we report a new function of secretin as a survival factor for neural progenitor cells in the hippocampus. We found that secretin-deficient mice exhibit decreased numbers of BrdU-labeled new neurons and dramatically increased apoptosis of doublecortin-positive neural progenitor cells in the subgranular zone of the dentate gyrus (DG) during the early postnatal period. Furthermore, we found that reduced survival of neural progenitor cells leads to decreased volume of DG, reduced long-term potentiation and impaired spatial learning ability in adults. Our studies demonstrate that secretin has important implications for neurogenesis in postnatal development, and affects neurobehavioral function in the adult mouse.
INTRODUCTION
The dentate gyrus (DG) in the hippocampus is one of the two major areas of a healthy brain that contribute to the lifelong production of new neurons. During neurogenesis, neuronal stem/progenitor cells first proliferate and produce newborn neurons, which then migrate into the granular layer and differentiate into their mature neuronal phenotype (1) . Adult neurogenesis is important for learning and memory and is affected under many physiological and pathophysiological conditions, including dietary restrictions (2, 3) , exercise (3) and neurobehavioral disorders (1) . Although the early postnatal period is a prominent stage of lifelong neurogenesis (4) , the functional role of neurogenesis in this developing stage has not been well characterized.
To understand the role of neurogenesis in postnatal development for lifelong hippocampal function, we evaluated secretin (Sct), a neuropeptide and a candidate molecule for modulating neurogenesis in the postnatal developing stage. Secretin is a peptide hormone that belongs to the secretin/VIP/glucagon peptide family. Although it was originally isolated in the gastrointestinal system (5, 6) , it has been found that secretin itself is produced in the brain and acts as a neuropeptide in the central nervous system (CNS) (7) . Interestingly, secretin gene and protein expression are higher during the early postnatal period (8) . In most brain regions, secretin mRNAs were more abundant in rats at postnatal days 7 and 14 when compared with rats at postnatal day 60, including the central amygdala (12-fold) , the hippocampus (8-fold), the cerebellum (3-fold) and the area postrema (3-fold) (8) . Furthermore, secretin expression is controlled by NeuroD1, a neurogenic bHLH transcription factor (9) . It was recently reported that NeuroD1 is required for the survival of neural progenitor cells in the hippocampus. We hypothesize that secretin may be a significant downstream pathway for control of the survival of neural progenitor cells, although likely one of several mechanisms induced by NeuroD1. However, the CNS function of secretin during the early postnatal period is totally unknown. Here, we report the new function of secretin as a survival factor during early postnatal neurogenesis. We found that secretin-deficient mice have poor survival of neuroprogenitor cells during the early postnatal period, and impaired long-term potentiation (LTP) and spatial learning in adulthood. Our findings demonstrate that secretin has important implications for neurogenesis in the developing period, and affects neurobehavioral function in the adult mouse.
RESULTS
Increased LacZ reporter expression during early postnatal period in Sct2/2 brain Previous work from this and other laboratories revealed that secretin gene expression was present in the granular layer and the subgranular zone (SGZ) in the DG of the hippocampus as well as the hilus and the molecular layer of the hippocampus, the posterior commissure, the habenula, the cerebellum, the olfactory glomeruli and dorsal tegmental nucleus in adult mice (7) . To further characterize secretin during postnatal development, we examined secretin expression in the postnatal period and identified enhanced expression around days 14 and 21 (Supplementary Material, Fig. S1 ). Therefore, we focused our brain analysis on postnatal day 21, the latest day of the higher Sct gene expression of the mice.
Sct2/2 mice have reduced hippocampal neurogenesis
To quantify proliferation and survival of newly generated cells in the hippocampal DG during the early postnatal period, we compared the DNA synthesis by measuring the incorporation of thymidine analogue bromodeoxyuridine (BrdU) in Sct2/2 and wild-type mice. To investigate proliferative events of neurogenesis, the mice were sacrificed 48 h after the last BrdU injection and their brains were sectioned for BrdU immunohistochemistry. A decreasing trend was observed in the number of BrdU-positive cells in the SGZ of Sct2/2 mice (n ¼ 11) compared with the wild-type mice (n ¼ 9), but this was not statistically significant [199 + 11.2 versus 226 + 10.3 cells, respectively; mean + standard error of the mean (SEM); P ¼ 0.08) (Fig. 1A) ]. To determine whether neurogenesis is decreased overall, the mice were sacrificed and sectioned for BrdU immunohistochemistry 3 weeks after the last injection. A significant decrease was found in the number of BrdU-positive cells surviving after 3 weeks in Sct2/2 mice (n ¼ 8), compared with wild-type mice (n ¼ 10) (41 + 2.3 versus 58 + 4.1 cells, respectively; mean + SEM; P , 0.01) (Fig. 1B and C ). This represents a 28% decrease in the number of cells surviving after 3 weeks. In summary, these data do not clearly show any involvement of secretin in the proliferation of neural stem cells, but indicate a significant effect of secretin upon the survival of newborn neurons.
Sct2/2 mice do not exhibit defects in differentiation of neuronal stem cells
To confirm the differentiation of the newborn cells into mature cell types, we examined BrdU-positive cells with neuronal and glial markers using immunohistochemistry. At 3 weeks postinjection, 88% of the wild-type (n ¼ 121) and 84% of Sct2/2 (n ¼ 160) BrdU-positive cells were co-labeled with NeuN, and no BrdU cells of either genotype were co-labeled with GFAP (Fig. 2) . Both percentages fall within the published range of NeuN staining in BrdU-positive cells (10, 11) , indicating that secretin likely has no effect on differentiation.
Sct2/2 mice have reduced survival of neuronal progenitor cells
To further investigate the effects of secretin on the survival of new neurons, we evaluated the apoptosis of neuronal progenitor cells and immature neurons in the DG by measuring the DNA strand break using the Terminal dUTP nick end-labeling (TUNEL) assay. TUNEL-positive cells were observed in the subgranular layer of the DG in both Sct-mutant and wild-type littermates that were labeled with BrdU at postnatal day 21. However, a 3.2-fold increase was observed in Sct-mutant mice (Sct2/2: 42.8 + 1.9 SEM versus wild-type: 13.2 + 0.6, P , 0.01) (Fig. 3B) . The TUNEL-positive cells colocalized with doublecortin (DCX), a neural progenitor/immature neural marker (Fig. 3C) . Although we detected elevation of apoptosis in the subgranular layer of the Sct-mutant DG of adult (5 months old) mice [Sct2/2: 1.9 + 0.3 SEM versus wild-type: 0.7 + 0.2, P , 0.01) (Fig. 3B) ], the total number of TUNEL-positive cells was not as high as in the early postnatal period. These results indicate that secretin plays a significant role for the survival of neural progenitor cells mainly in the postnatal developing period. To analyze how the deficiency of neurogenesis during the developing period affects the adult brain, we quantified the volume of DG. Stereological analysis showed that there is no significant difference in DG volume between Sct-deficient and wild-type mice at postnatal day 28. However, after 1 year, the DG volume was reduced by 20% in the mutant brain (P , 0.01) (Fig. 4) . Although other mechanisms may be involved in a reduction of granule cell numbers occurring over the time of 1 year, these data may indicate that survival deficiency in Sct-mutant neural progenitor cells during early postnatal hippocampal development may result in a decrease of adult DG size.
Impaired LTP in Sct2/2 DG
Enhanced expression of secretin in the subgranular region of the DG was observed during the early postnatal period, an active synaptogenesis period, and Sct2/2 mice exhibit deficits in the survival of neuronal progenitor cells/young neurons in the DG. These results suggest that secretin may play a role in synaptic formation and function in the DG. To better understand how the absence of secretin can affect synaptic function in the DG, the perforant pathway was stimulated and synaptic transmission and plasticity was determined. Previously, we reported that while the loss of secretin had deleterious effects on LTP in the CA1 of the hippocampus, no significant differences in the basal synaptic function were observed in the CA1 area (7). To better understand whether the basal synaptic transmission in the DG is altered in Sct2/2 mice, an input/output (I/O) curve was generated by incrementally increasing the voltage every 0.5 mV until the maximum amplitude of the field excitatory post-synaptic potential (fEPSP) was reached. These curves were evaluated by determining the maximum slope of each slice, designating the maximum slope as 100% and standardizing the smaller slopes as a percentage of the maximum slope. The slopes were plotted against the corresponding voltage step, and a non-linear regression line was best fit. While this is not a standard I/O curve, this method was used because fiber volleys through stimulation of the perforant pathway are difficult to detect. There were no significant alterations to basal synaptic function between Sct2/2 (n ¼ 8) or wt (n ¼ 8) half-life, span or plateau of the non-linear best-fit curves of the I/O curve (Fig. 5A ). These data are consistent with previous results that demonstrate that the loss of secretin does not have an effect on basal synaptic transmission. To determine whether the loss of secretin altered LTP in the DG, a modest protocol consisting of two trains of tetani (2× 1 s, 100 Hz train separated by 20 s) was used to induce LTP (Fig. 5B ). Loss of secretin had a deleterious effect on overall high-frequency stimulation (HFS)-induced LTP at the dendritic synapses (Fig. 5C ). Immediately following HFS, acute hippocampal slices taken from Sct2/2 mice had significant deficits in the average post-tetanic potentiation (PTP, Fig. 5D , average of first 2 min, P , 0.01). Furthermore, there were significant decreases in the average LTP of slices taken from Sct2/2 mice ( Fig. 5E ; average of last 5 min; P , 0.05). These data are consistent with our previous findings that the presence of secretin is necessary for normal hippocampal plasticity in both the CA1 region and now the DG. However, the importance of the secretin receptor in the regulation of hippocampal-dependent LTP in the DG remains unclear.
Sct2/2 mice exhibit impaired spatial learning ability
Hippocampal neurogenesis is known to be associated with learning and memory (12, 13) . Previous studies have demonstrated that the secretin gene is expressed in several areas of the brain, including the hippocampus, and that secretin deficiency causes impairment of synaptic plasticity in the hippocampus (7). To determine whether impaired hippocampal synaptic plasticity is associated with any significant behavioral defects, we examined spatial learning and memory of the mutant mice using the water maze, a hippocampal-dependent spatial task. Sct mutant (n ¼ 10) and wild-type (n ¼ 11) mice were trained in eight blocks of trials, and their latency and distance to reach a hidden platform was recorded. No difference was found between Sct2/2 and wild-type mice in the training phase of the water maze; both cohorts demonstrated a decrease in the latency to find the hidden platform over eight trial sessions (Fig. 6A) . However, when the hidden platform was moved to a new location in the reversal training phase of the water maze, Sct2/2 mice took significantly longer to find the platform than did the wild-type mice (Fig. 6B) . Furthermore, Sct2/2 mice demonstrated a trend toward a preference for the first location of the hidden platform (Fig. 6D) . These results suggest that Sct-deficient mice are impaired in their ability to re-form association memories in order to accomplish a task and are thus more resistant to a change in routine. To make sure that the deficits were learning-specific, we tested motor coordination and sensory motor activity by using the rotarod and hot plate tests. No significant differences were found in either motor coordination or sensorimotor activity between Sct2/2 and wild-type littermates (Supplementary Material, Fig. S2 ). Therefore, Sct-mutant mice appeared to have specific spatial learning deficits.
DISCUSSION
In this study, we explored the role of secretin in hippocampal neurogenesis during the postnatal developing period and analyzed how this affects hippocampus-related neuronal and behavioral phenotypes in adult mice. Secretin is a member of the secretin-glucagon peptide hormone family (14) . Although other peptide hormones in the family, including VIP and PACAP, have been reported to provide neuroprotection (15) , the function of secretin has not been clearly identified. Our study is the first report to show that secretin promotes the survival of neural progenitor cells, and indicates that secretin is important for normal neurobehavioral development.
We observed impaired proliferation and survival of neural progenitor cells in Sct2/2 hippocampus by measuring DNA synthesis using BrdU incorporation and apoptosis by DNA end-labeling (TUNEL) methods. Since massive neurogenesis occurs during the early postnatal period and expression of Sct and Sctr is higher than in the adult brain, we analyzed hippocampal neurogenesis in mutant pups at postnatal day 21. In Sct2/2 mice, the number of BrdUlabeled new neurons was significantly decreased and apoptosis of DCX-positive neural progenitor cells was dramatically increased. Apoptosis is involved in normal processes of neuronal integration and is important for the establishment of optimal synaptic connectivity. Overexpression of the apoptotic suppressor Bcl-2 produces the opposite effect than our mice (16) , which leads to increased hippocampal volume. In adult neurogenesis, apoptosis normally occurs in the third week following proliferation. This immediately follows the beginning of dendritic spine formation at day 16 (17) . Thus, synaptogenesis and apoptosis are active during the same period in newly proliferated neurons, and each likely influences the other. We previously reported that secretin receptor signaling is important for dendritic spine formation in the hippocampal CA1 region. In a future study, we plan to investigate the role of secretin for dendritic spine formation and apoptosis in the DG region.
The concept of competitive, activity-dependent neuronal maturation provides an elegant mechanism for the effect of secretin on neuronal survival. The importance of synaptic activity to neurogenesis has been clearly shown by the induction of LTP in several experimental paradigms (18 -20) . Accordingly, although our electrophysiological studies focused on the functional deficit of synaptic transmission in secretin-deficient mice, the findings of decreased LTP in secretin-deficient mice could represent the loss of a significant contributor to synaptic activity, which is important for neuronal maturation and survival.
Secretin gene expression is controlled by NeuroD1, a basic helix-loop-helix transcription factor (9). In the NeuroD1-deficient mice, secretin production is completely blocked (21) . These studies lay the groundwork for further studies of the signaling mechanisms involved in the effect of secretin on neuronal survival. Elements both upstream and downstream of secretin are known to be important in neurogenesis. The upstream transcription factor NeuroD1 is situated at a critical junction in the differentiation of self-renewing neural stem cells to actively proliferating neural progenitors (22, 23) . Thus, NeuroD1 is expressed in neuronal progenitor cells and young neurons in CNS, but is not expressed in pluripotent neuronal stem cells. In addition, NeuroD1 is involved in postnatal brain development (24, 25) . Without NeuroD1, the DG granule cell layer fails to develop (24, 25) . Recent reports have demonstrated that NeuroD supports survival of new neurons in the SGZ of the DG (23, 26) . This suggests the possibility that the survival activity of NeuroD in new neurons may be at least partially through secretin signaling. The receptor for secretin is a G-protein-coupled receptor, and downstream activity of the secretin receptor is mainly through cyclic adenosine monophosphate (cAMP), although it may also participate in other signaling pathways (27) . cAMP and cAMP response element binding protein (CREB) are known to be important for neuronal maturation in the hippocampus (28) (29) (30) . Future studies will determine whether secretin merely contributes to a general effect on neurogenesis through activation of the cAMP signaling pathway, or whether it activates separate mechanisms for more specific effects.
Increasing evidence shows that neurogenesis is important for maintaining neurobehavioral function throughout the life (1). Likewise, clinical trials in which patients were administered single or multiple injections of secretin peptide produced isolated reports of neurobehavioral improvement in autism and schizophrenia (31) (32) (33) (34) . Though most studies showed no effect of secretin (35) , the mechanism of action showed an increase in dopamine metabolism in improved patients (32) . Further research is needed to identify the mechanism of secretin function.
In summary, we demonstrated that secretin is required for synapse formation, as well as for the survival of neural progenitors/immature neurons that subsequently affect neuropsychological functions throughout the life of the mouse. Understanding the basic mechanism of secretin signaling in neurogenesis will provide valuable insight that may benefit neurological health in the future. Increasing evidence shows that neurogenesis is altered under many physiological and pathophysiological conditions. These studies of the basic mechanism of secretin signaling will have important implications for understanding of neurogenesis in health, and may provide insight into the mechanism of neurobehavioral disorders.
MATERIALS AND METHODS

Animals
All procedures were approved by The Research Institute at Nationwide Children's Hospital Institutional Animal Care and Use Committee. Mice were bred and housed in a SPF transgenic mouse barrier facility, with a 12 h light/dark cycle. Secretin-deficient mice and wild-type littermates were generated by mating heterozygous mutant parents.
The generation of secretin-deficient mice has been previously described (7) . Briefly, a gene-targeting vector was created to replace the entire coding region of the Sct gene with a beta-galactosidase (LacZ) reporter gene. This construct was electroporated into mouse strain 129S5 embryonic stem cells, which were then injected into blastocysts. Blastocysts 
BrdU labeling and immunohistochemistry
Each animal was injected with bromodeoxyuridine (BrdU; Sigma, St Louis, MO, USA; dissolved in 0.9% sodium chloride) once every 24 h for 7 days, at a dose of 50 mg/kg body weight. The brain samples were collected either 2 days after the last BrdU injection for cell proliferation studies or 3 weeks after the last BrdU injection for cell differentiation and survival studies. The mice were deeply anesthetized and perfused transcardially with phosphate-buffered saline (PBS), followed by 4% paraformaldehyde in PBS. A series of 40 mm coronal brain sections were obtained with Vibratome VT1000 (Vibratome, St Louis, MO, USA). Hippocampal sections containing SGZs were collected at 240 mm intervals, in the corresponding region of 21.35 to 23.28 mm bregma. Free-floating sections were rinsed in Tris-buffered saline (TBS), incubated in 50% formamide in a 2X saline-sodium citrate buffer and then incubated in 2N hydrochloric acid. Sections were rinsed with 0.1 M borate buffer, and with TBS. Sections were then incubated in rat anti-BrdU primary antibody (1:400, Accurate Chemical, Westbury, NY, USA) at 48C for 72 h. After rinsing with TBS, sections were incubated in FITC-conjugated donkey anti-rat IgG (1:125, Jackson ImmunoResearch, West Grove, PA, USA) at RT for 2 h. The sections were coverslipped with mounting media (Vector Laboratories, Burlingame, CA, USA) containing 1 mg/ml of the nuclear stain 4 ′ ,6-diamidino-2-phenylindole (DAPI). For NeuN or GFAP staining, sections were incubated in mouse anti-NeuN (1:500, Millipore, Billerica, MA, USA) or mouse anti-GFAP antibody (1:500, Sigma-Aldrich) at 48C for 48 h. The sections were incubated in Cy3-conjugated goat antimouse IgG (1:500, Jackson ImmunoResearch) in blocking solution and used for BrdU double labeling as described above.
BrdU-positive cell counting
BrdU-positive cells were counted in the SGZ using the ×40 objective of a Nikon Eclipse E800 fluorescence microscope. For practical purposes of counting, the region of interest was defined by the interface of the granule cell layer and the hilus as delineated by DAPI staining of granule cell nuclei. All BrdU-positive cells lying within three cell widths on either side of this border were counted, to include both stem/progenitor cells and newborn neurons within the granule cell layer. The experimenter was blind to the genotypes of the mice for all quantification. For statistical analysis, cell counts from at least seven (range: 7 -31; mean: 14) sections were averaged to generate the number of BrdU-positive cells per DG section in each animal. The per-animal means were then averaged by cohort to obtain the mean number of BrdU-labeled cells per DG for each genotype and time point as reported in Figure 1 . Cohort means were tested for statistical significance by unpaired Student's t-test analysis.
Cells double-labeled with BrdU and NeuN or GFAP were imaged using a ×63 objective on a Zeiss laser-scanning confocal microscope. BrdU-labeled cells with or without NeuN or GFAP were counted to determine the percentage of newborn cells that had begun to differentiate into mature neurons or astrocytes.
TUNEL assay and stereological analyses
Apoptotic neuronal cell death in the DG at postnatal day 21 and adult stage was detected by the TUNEL method using the ApopTag In Situ Apoptosis Detection kit (Millipore). All images were obtained on a Nikon Eclipse E800 microscope equipped with SPOT Diagnostics imaging software. The number of TUNEL-positive cells in the SGZ was counted and compared statistically between genotypes by unpaired Student's t-test analysis. Stereological volume analysis in the DG of the hippocampus was performed in mice at 4 weeks and 1 year old by Cavalier estimator in Stereo Investigator (MBF Bioscience, Williston, VT, USA).
Hippocampal slice preparation and electrophysiology
Hippocampal slice preparation and electrophysiology were performed as described previously (36) (37) (38) . fEPSPs were obtained from DG with the use of a glass microelectrode filled with artificial cerebrospinal fluid (2-4 mV). fEPSPs were evoked through stimulation of the perforant pathway using a 0.1 ms biphasic pulse delivered every 20 s. After a consistent response to a voltage stimulus was established, threshold voltage for evoking fEPSPs was determined and the voltage was increased incrementally every 0.5 mV until the maximum amplitude of the fEPSP was reached (I/O curve). A fEPSP baseline response, defined as 50% of the stimulus voltage used to produce the maximum fEPSP amplitude, was then recorded for 20 min. Paired-pulse inhibition was induced with two paired pulses given with an initial delay of 20 ms and the time to the second pulse incrementally increased 20 ms until a final delay of 300 ms was reached. The tetanus used to evoke LTP was a HFS protocol, which consisted of 1 s, 100 Hz train given twice with an inter-train interval of 20 s. Following HFS, fEPSPs evoked by baseline stimulus were recorded every 20 s for 60 min. Potentiation was measured as the increase of the mean fEPSP descending slope following HFS normalized to the mean fEPSP descending slope of baseline recordings. Data from synaptic transmission was evaluated using the Mann -Whitney test and paired-pulse facilitation, and LTP experiments were analyzed using Student's t-test analysis.
Behavioral testing
The mice were tested for spatial learning using a hidden platform water maze task, and motor coordination was assessed by a rotarod test, as described previously (39) . Briefly, the swim path of the animal in the water pool was recorded with Smart 2.0 tracking software (San Diego Instruments, San Diego, CA, USA). The pool area was divided by the software into four quadrants for analysis of the swim path. The starting location of the mouse was varied randomly in each trial, so that the mice would need to learn the visual cues placed on the surrounding walls in order to find the hidden platform. For the training phase, a platform was hidden in the water with nontoxic white paint, and the path and time the animal required to find the platform was recorded. For the reversal phase, trials were conducted in the same way, but the location of the hidden platform was moved to the opposite side of the tub. For the probe tests, the mice were allowed to swim for 60 s in the tub with no hidden platform.
